NABH Covid-19 Resources – Draft

Updated: April 13, 2020

This NABH-Covid-19 Resources page is designed to help NABH members access important and applicable resources as they navigate the Covid-19 pandemic. The first section includes PDF documents from NABH and other organizations, and the second section includes links to federal guidance and other applicable information from federal agencies and non-government organizations.

Thank you for the excellent care you and your teams continue to provide during this difficult time. Please write to us with concerns or questions at nabh@nabh.org.

Infection Control

• 4-9-20: CMS Updated Guidance on Infection Control for ICF/IID & PRTF
• 4-9-20: CMS Updated Guidance on Infection Control for Hospitals
• CDC Covid-19 and Infection Control Guidance
• CMS Infection Control Guidance for Outpatient Settings
• The Joint Commission’s Covid-19 Infection Control Guidance
• National Institute of Environmental Health Sciences Resources

CARES Act

• 4-6-20: AHA Urges SBA to Ensure Hospitals Can Participate in CARES Act Loan Program
• 4-3-20: Holland & Knight Healthcare Blog on Covid-19 Funding for Healthcare Providers

CDC

• CDC Guidance for Healthcare Providers
• Covid-19 and Healthcare Facilities Guidance

• CMS Medicare Provider Enrollment Relief FAQs
• CMS 1135 Waiver Checklist Template CMS Guidance 1135

SAMHSA:

• SAMHSA letter to AATOD confirming that OTPs provide essential health services and are legitimate personal protective equipment purchasers
• SAMHSA Covid-19 Resources and Information
• Social Distancing, Quarantine, and Isolation Guidance
• Considerations for Mental Health and SUD Treatment
• Considerations for Alcohol-Benzodiazephine Withdrawal
• OTP Guidance
• OTP Doorstep Delivery Guidance
• 42 CFR Part 2 Guidance
• Virtual Recovery Resources
• Disaster Planning Handbook

NIDA

• Covid-19 Emerging Trends and Alerts
• Covid-19 Potential Implications for Individuals with SUD

HHS Office for Civil Rights

• Guidance on HIPAA and Telehealth
• February Guidance on Covid-19 and HIPAA

National Academy for State Health Policy

• State Strategies for OUD Treatment During Covid-19 Pandemic

American Society of Addiction Medicine

ASAM Covid-19 Resources (4-2-20)

Personal Protective Equipment (PPE)

• CDC Strategies on Optimizing PPE Supply
• FDA Guidance on Emergency Use Authorization for PPE
  • Guidance on Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (REVISED)
  • Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators
  • NIOSH-Approved Air Purifying Respirators for Use in Health Care Settings During Response to the COVID-19 Public Health Emergency
  • Battelle Decontamination System
  • Enforcement Policy for Gowns, Other Apparel, and Gloves

• CMS Announces Relief for Quality Reporting Programs
• CMS Guidance for Healthcare Providers
• CMS Virtual Toolkit
• CMS Guidance on section 1135 authority that allows waiver of certain Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) requirements

• CMS Covid-19 and EMTALA Memo
• CMS Guidance on 1135 Waiver Authority

• 4-6-20: CMS Video on Telehealth Benefits Questions
• 4-2-20: DEA and SAMSHA Release Guidance on Buprenorphine and Telemedicine
• 3-24-20: CMS Telehealth March 24 FAQs
• CMS 2020 Telehealth Services Booklet
• Telehealth Coverage Policies Summary from the Center for Connected Health Policy
• CMS Guidance and FAQs on Telehealth in Medicare
• CMS Guidance on Telehealth in Medicaid
• HHS Office of Inspector General (OIG) Policy Statement and Fact Sheet on Telehealth Cost-Sharing
• HHS Office for Civil Rights Guidance on Waiver of HIPAA Sanctions and Penalties Related to Telehealth
• Drug Enforcement Administration Guidance on Telemedicine and Medication-Assisted Treatment

• 4-6-20: OIG Statement on Administrative Enforcement Authorities due to Covid-19 Emergency
• 4-6-20: Federal Trade Commission Webpage About Covid-19 Consumer Protections
• Updated 4-2-20: U.S. Labor Department’s FAQs on the Families First Coronavirus Response Act 
• HHS’ Office of Inspector General released a COVID-19 Fraud Alert with general information
• Kaiser Family Foundation Medicaid Emergency Authority Tracker
• National Governors Association Covid-19 Updates
• HHS Office of Inspector General’s Covid-19 Portal
• The Joint Commission’s Webinar on Preparing Behavioral Health Organizations for Covid-19
• HRSA Covid-19 Funding, Resources, and Oversight FAQs
• HRSA Technical Assistance for Award Recipients

NABH’s Covid-19 Task Force works with the NABH team in Washington to identify the most challenging issues facing U.S. behavioral healthcare providers during the Covid-19 pandemic. The task force will also develop recommendations that NABH will share with relevant federal agencies, congressional offices, and the general public.

• Anne Kelly, Ed.D., B.S.N., Chair, Acadia Healthcare
• John Boyd, PsyD., F.A.C.H.E., Sutter Health, System Mental Health Services
• Brian J. Brooker, DHSc, RN-BC NE-BC, M.H.A., H.A.C.P., C.A.R.T., Signature Healthcare Services
• Pat Connell, R.N., M.B.A., F.A.C.H.E., C.B.H.E., C.H.C., Boys Town Behavioral Health Division
• Frank Fortunati, Jr., M.D., J.D., Yale New Haven Psychiatric Hospital
• Michael Genovese, M.D., J.D., Acadia Healthcare, Inc.
• Frank A. Ghinassi, Ph.D., A.B.P.P., Chair, Rutgers University Behavioral Health Care
• Michele Gougeon, McLean Hospital
• Karen Johnson, M.S.W., Universal Health Services, Inc.
• Chris Roussos, Sequel Youth and Family Services
• Francis Sauvageau, New Season/Colonial Management Group, LP
• Mark Schneider, Vizion Health, LLC
• Dominic Sirianni, L.M.H.C., C.A.P., Delphi Behavioral Health Group
• Kristen Tefft, M.H.I., R.H.I.A., Springstone, Inc.
• Harsh K. Trivedi, M.D., M.B.A., Sheppard Pratt Health System
• Kirsten K. Beronio, J.D., Staff Liaison,  National Association for Behavioral Healthcare